Medical Needle-Free Injection Market Analysis 2025 – Insights for Long-Term Investment & Planning
The Business Research Company
The Business Research Company's Medical Needle-Free Injection Market Analysis 2025 – Insights for Long-Term Investment & Planning
LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts Through 2034
What Is The Growth Trajectory Of The Medical Needle-Free Injection Market?
The global medical needle-free injections market has seen an impressive surge in recent years. The market size, which stood at $14.36 billion in 2024, is projected to grow to $16.25 billion in 2025 at a compound annual growth rate CAGR of 13.2%. The growth during the historic period is majorly driven by the increasing demand for painless drug delivery, rise in self-administration of medications, growing preference for minimally invasive procedures, increasing adoption of home healthcare solutions as well as rising demand for needle-free alternatives.
What Is The Expected Market Size For The Medical Needle-Free Injection By 2029?
According to The Business Research Company’s Latest Report, the medical needle-free injection market is likely to witness rapid expansion in the next few years. Bolstering this growth is an increasing technological advancements in drug delivery systems, rising demand for personalized medicine, growing focus on patient comfort and convenience, expansion in biologics and biosimilars market, and increasing healthcare expenditures in emerging economies. The market is projected to grow to $26.33 billion in 2029 at a compound annual growth rate CAGR of 12.8%. Furthermore, major trends in the forecast period include advancement in jet injection technology, development of more compact and portable devices, innovation in combination drug delivery systems, advancement in microneedle technology for painless injections, and development of multi-dose needle-free injectors.
Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24304&type=smp
What Factors Are Driving Growth In The Medical Needle-Free Injection Market?
The increasing number of diabetes patients is expected to propel market growth. Diabetes, a chronic medical condition where the body cannot properly regulate blood sugar or glucose levels, is primarily driven by rising obesity rates, which increase the likelihood of developing type 2 diabetes. Medical needle-free injections offer diabetes patients a painless, non-intimidating way to administer insulin or other medications through high-pressure technology. This approach not only reduces discomfort, but also alleviates needle anxiety and enhances patient adherence to treatment. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner GP were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/medical-needle-free-injection-global-market-report
Who Are The Key Players In The Medical Needle-Free Injection Market?
Major players operating in the medical needle-free injection market include Pfizer Inc., Medline Industries LP., Daicel Corporation, AptarGroup Inc., Gerresheimer AG, Portal Instruments, Inovio Pharmaceuticals Inc., PharmaJet Inc., RPK Group, National Medical Products Inc., Mika Medical, Injex Pharma AG, Crossject SA, InsuJet, NuGen Medical Devices Inc., Robbins Instruments, PICOCYL, MIT Canada Inc., AcuShot Needle Free, and FlowBeams. These industry giants are expected to continue playing a pivotal role in shaping the market dynamics.
What Are The Emerging Trends In The Medical Needle-Free Injection Market?
Industry players, in a bid to maintain an edge, are focusing on developing advanced products like jet-based needle-free injection systems to enhance drug delivery efficiency and minimize patient discomfort. Notably, in November 2024, Sol-Millennium Medical Group, a US-based manufacturer of medical devices, launched the InsuJet, a needle-free insulin injection device, in Canada.
How Is The Medical Needle-Free Injection Market Segmented?
1 By Product Type: Jet-Based Needle-Free Injectors, Spring-Based Needle Free Injectors, Laser-Powered Needle Free Injectors, Vibration-Based Needle Free Injectors
2 By Mode Of Delivery: Subcutaneous Delivery, Intramuscular Delivery, Intradermal ID Delivery, Intravenous IV Delivery
3 By Application: Vaccine Delivery, Insulin Delivery, Pain Management, Oncology, Other Applications
4 By End-User: Hospitals, Clinics, Home Care Settings, Research Laboratories, Other End-Users
What Are The Regional Insights Into The Medical Needle-Free Injection Market?
North America was the largest market in 2024. Asia-Pacific, on the other hand, is expected to be the fastest-growing region during the forecast period. The regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Browse Through More Similar Reports By The Business Research Company:
Medical Device Testing Services Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/medical-device-testing-services-global-market-report
Medical Devices Vigilance Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/medical-devices-vigilance-global-market-report
Medical Biomimetics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/medical-biomimetics-global-market-report
The Business Research Company, a firm with over 15000+ reports from 27 industries covering 60+ geographies, is at the forefront of delivering comprehensive, data-rich research and insights, providing a competitive edge to stay ahead in the game. The company with 1,500,000 datasets combines in-depth secondary research, optimistic contribution, and unique insights from industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info|tbrc.info| |info|tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Reverse Med Bar Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
GenH2 Senior Technology Advisor Honored with Prestigious NASA Recognition
Mary-Beth Newell Reveals the Secrets to Youthful Living with 'Anti-Aging and Secrets of Healthy Living to Stop the Clock!'
Więcej ważnych informacji
Jedynka Newserii
Jedynka Newserii
Finanse
K. Gawkowski: Polska w cyfrowej transformacji gospodarki awansowała do pierwszej ligi w Europie. 2,8 mld zł z KPO jeszcze ten proces przyspieszy
Uruchomiony na początku lipca przez Ministerstwo Cyfryzacji i BGK program „KPO: Pożyczka na cyfryzację” cieszy się dużym zainteresowaniem. Samorządy, uczelnie oraz firmy mogą wnioskować o wsparcie finansowe dla inwestycji w transformację cyfrową, m.in. modernizację infrastruktury czy cyberbezpieczeństwo. W sumie na ten cel trafi 2,8 mld zł (650 mln euro). Ze względu na krótki czas naboru obie instytucje organizują w poszczególnych województwach warsztaty dla wnioskodawców, które mają rozwiać ich wątpliwości przy przygotowywaniu wniosków.
Prawo
Koszty certyfikacji wyrobów medycznych sięgają milionów euro. Pacjenci mogą stracić dostęp do wyrobów ratujących życie
Od 2027 roku wszystkie firmy produkujące wyroby medyczne w Unii Europejskiej będą musiały posiadać certyfikat zgodności z rozporządzeniem MDR (Medical Devices Regulation). Nowe przepisy wprowadzają dużo ostrzejsze wymagania w zakresie dokumentacji, badań klinicznych oraz procedur certyfikacyjnych. Branża ostrzega, że część małych i średnich producentów nie zdąży się dostosować. Problemem jest także wysoki koszt i długi czas uzyskiwania certyfikatów. W konsekwencji z rynku mogą zniknąć urządzenia ratujące życie.
Infrastruktura
Nowe przepisy o ochronie ludności cywilnej wprowadzają obowiązkowe elastyczne zbiorniki na wodę. Mają one służyć w razie suszy, pożarów czy wybuchu wojny
Samorządy będą musiały posiadać m.in. elastyczne zbiorniki na wodę pitną i przenośne magazyny wody przeciwpożarowej. To element odpowiedniego przygotowania zasobów na wypadek sytuacji kryzysowych, kataklizmów czy wybuchu konfliktu, wprowadzony nowymi przepisami o ochronie ludności. Eksperci podkreślają, że tego typu rozwiązania to innowacyjne produkty, które nie tylko ułatwiają logistykę w sytuacjach kryzysowych, ale także mogą znacząco skrócić czas reakcji służb ratunkowych.
Partner serwisu
.gif)
Szkolenia
Akademia Newserii
Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.
|
|
|